Skip to main content

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Insulin aspart (Fiasp) for treating diabetes mellitus
Drug guidance

Insulin aspart (Fiasp) for treating diabetes mellitus

Condition

Endocrine and metabolic

2 January 2024

Published on 02 Jan 2024
Last Updated on 02 Jan 2024

Guidance Recommendations

The Ministry of Health’s Drug Advisory Committee has not recommended insulin aspart (Fiasp) for inclusion on the MOH List of Subsidised Drugs for treating diabetes mellitus due to limited clinical need and unfavourable cost effectiveness compared with alternative treatments.

Insulin aspart (Fiasp) for treating diabetes mellitus (Published 2 Jan 2024) [PDF, 88 KB]

Back to top